Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 21
Filtrar
1.
Eur J Hum Genet ; 30(10): 1147-1154, 2022 10.
Artículo en Inglés | MEDLINE | ID: mdl-35577937

RESUMEN

Rapid advances in the genetics of psychiatric disorders mean that diagnostic and predictive genetic testing for schizophrenia risk may one day be a reality. This study examined how causal attributions for schizophrenia contribute to interest in a hypothetical genetic test. People with schizophrenia and first-degree relatives of people with schizophrenia were recruited through a schizophrenia research bank and mental health organisation. Semi-structured telephone interviews were conducted with 13 individuals with schizophrenia and 8 first-degree relatives. Transcripts were subjected to a qualitative analysis using the thematic analysis framework. Five themes were developed: (i) "It is like a cocktail", with most participants aware that both genetic and environmental factors contributed to causation, and many mentioning the positive impact of genetic causal explanations; (ii) "Knowledge is power" (i.e., in favour of genetic testing); (iii) Genetic testing provides opportunities for early intervention and avoiding triggers, with participants citing a wide range of perceived benefits of genetic testing but few risks; (iv) Views on reproductive genetic testing for schizophrenia risk with a few participants viewing it as "playing God" but not necessarily being against it; and (v) "It snowballs", whereby participants' understanding of genetics was sophisticated with most believing that multiple rather than single genes contributed to schizophrenia. In conclusion, many individuals had a sound understanding of the role of genetic testing if it were to become available, with evidence of insight into the role of multiple genes and the contribution of other risk factors that may interact with any inherited genetic risk.


Asunto(s)
Esquizofrenia , Actitud , Concienciación , Pruebas Genéticas , Humanos , Factores de Riesgo , Esquizofrenia/diagnóstico , Esquizofrenia/genética
2.
Hum Antibodies ; 16(3-4): 163-76, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-18334751

RESUMEN

Over-expression of the enzyme human aspartyl (asparaginyl) beta-hydroxylase (HAAH) has been detected in a variety of cancers. It is proposed that upon cellular transformation, HAAH is overexpressed and translocated to the tumor cell surface, rendering it a specific surface antigen for tumor cells. In this work, twelve human single-chain Fv fragments (scFv) against HAAH were isolated from a human non-immune scFv library displayed on the surface of yeast. Five of the twelve were reformatted as human IgG1. Two of the five IgGs, 6-22 and 6-23, showed significant binding to recombinant HAAH in ELISA, tumor cell lines, and tumor tissues. The apparent dissociation constants of 6-22 and 6-23 IgG were 1.0 +/- 0.2 nM and 20 +/- 10 nM respectively. These two antibodies were shown to target different domains of HAAH, with 6-22 targeting the catalytic domain of HAAH and 6-23 targeting the N-terminal non-catalytic domain of HAAH. 6-22 IgG was further characterized, as it had high affinity and targeted the catalytic domain. 6-22 IgG alone does not exhibit significant cytotoxicity toward the tumor cells. However, 6-22 internalizes into tumor cells and can therefore be employed to deliver cytotoxic moieties. A goat anti-human IgG-saporin conjugate was delivered into tumor cells by 6-22 IgG and hence elicited cytotoxicity toward the tumor cells in vitro. These tumor-binding human antibodies can potentially be used in both diagnosis and immunotherapy targeting HAAH-expressing tumor cells.


Asunto(s)
Fragmentos de Inmunoglobulinas/inmunología , Inmunoglobulina G/inmunología , Oxigenasas de Función Mixta/inmunología , Secuencia de Aminoácidos , Citotoxicidad Celular Dependiente de Anticuerpos , Línea Celular Tumoral , Ensayo de Inmunoadsorción Enzimática , Humanos , Fragmentos de Inmunoglobulinas/biosíntesis , Fragmentos de Inmunoglobulinas/uso terapéutico , Inmunohistoquímica , Inmunotoxinas/uso terapéutico , Datos de Secuencia Molecular
3.
Cell Immunol ; 192(2): 175-84, 1999 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-10087186

RESUMEN

T cell receptors (TCR) and major histocompatibility complex (MHC) molecules are integral membrane proteins that have central roles in cell-mediated immune recognition. Therefore, soluble analogs of these molecules would be useful for analyzing and possibly modulating antigen-specific immune responses. However, due to the intrinsic low-affinity and inherent solubility problems, it has been difficult to produce soluble high-affinity analogs of TCR and class II MHC molecules. This report describes a general approach which solves this intrinsic low-affinity by constructing soluble divalent analogs using IgG as a molecular scaffold. The divalent nature of the complexes increases the avidity of the chimeric molecules for cognate ligands. The generality of this approach was studied by making soluble divalent analogs of two different classes of proteins, a TCR (2C TCR2Ig) and a class II MHC (MCCI-Ek2Ig) molecule. Direct flow cytometry assays demonstrate that the divalent 2C TCR2Ig chimera retained the specificity of the native 2C TCR, while displaying increased avidity for cognate peptide/MHC ligands, resulting in a high-affinity probe capable of detecting interactions that heretofore have only been detected using surface plasmon resonance. TCR2IgG was also used in immunofluorescence studies to show ER localization of intracellular peptide-MHC complexes after peptide feeding. MCCI-Ek2Ig chimeras were able to both stain and activate an MCC-specific T cell hybridoma. Construction and expression of these two diverse heterodimers demonstrate the generality of this approach. Furthermore, the increased avidity of these soluble divalent proteins makes these chimeric molecules potentially useful in clinical settings for probing and modulating in vivo cellular responses.


Asunto(s)
Antígenos de Histocompatibilidad Clase II/metabolismo , Receptores de Antígenos de Linfocitos T/metabolismo , Proteínas Recombinantes de Fusión/metabolismo , Secuencia de Bases , Dimerización , Antígenos de Histocompatibilidad Clase II/química , Humanos , Hibridomas/inmunología , Inmunoglobulina G/metabolismo , Activación de Linfocitos , Datos de Secuencia Molecular , Receptores de Antígenos de Linfocitos T/química , Proteínas Recombinantes de Fusión/química
4.
J Exp Med ; 188(9): 1633-40, 1998 Nov 02.
Artículo en Inglés | MEDLINE | ID: mdl-9802975

RESUMEN

The interaction of the T cell receptor (TCR) with its cognate peptide-major histocompatibility complex (MHC) on the surface of antigen presenting cells (APCs) is a primary event during T cell activation. Here we used a dimeric IEk-MCC molecule to study its capacity to activate antigen-specific T cells and to directly analyze the role of CD4 in physically stabilizing the TCR-MHC interaction. Dimeric IEk-MCC stably binds to specific T cells. In addition, immobilized dimeric IEk-MCC can induce TCR downregulation and activate antigen-specific T cells more efficiently than anti-CD3. The potency of the dimeric IEk-MCC is significantly enhanced in the presence of CD4. However, CD4 does not play any significant role in stabilizing peptide-MHC-TCR interactions as it fails to enhance binding of IEk-MCC to specific T cells or influence peptide-MHC-TCR dissociation rate or TCR downregulation. Moreover, these results indicate that dimerization of peptide-MHC class II using an IgG molecular scaffold significantly increases its binding avidity leading to an enhancement of its stimulatory capacity while maintaining the physiological properties of cognate peptide-MHC complex. These peptide-MHC-IgG chimeras may, therefore, provide a novel approach to modulate antigen-specific T cell responses both in vitro and in vivo.


Asunto(s)
Antígenos de Diferenciación de Linfocitos T/metabolismo , Antígenos de Histocompatibilidad Clase II/metabolismo , Activación de Linfocitos/inmunología , Linfocitos T/inmunología , Animales , Línea Celular , Dimerización , Regulación hacia Abajo , Inmunoglobulina G/metabolismo , Cinética , Ligandos , Complejo Mayor de Histocompatibilidad , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Péptidos/química , Péptidos/inmunología , Receptores de Antígenos de Linfocitos T/metabolismo , Proteínas Recombinantes de Fusión/química , Proteínas Recombinantes de Fusión/inmunología
5.
J Exp Med ; 186(8): 1333-45, 1997 Oct 20.
Artículo en Inglés | MEDLINE | ID: mdl-9334373

RESUMEN

Understanding the regulation of cell surface expression of specific peptide-major histocompatibility complex (MHC) complexes is hindered by the lack of direct quantitative analyses of specific peptide-MHC complexes. We have developed a direct quantitative biochemical approach by engineering soluble divalent T cell receptor analogues (TCR-Ig) that have high affinity for their cognate peptide-MHC ligands. The generality of this approach was demonstrated by specific staining of peptide-pulsed cells with two different TCR-Ig complexes: one specific for the murine alloantigen 2C, and one specific for a viral peptide from human T lymphocyte virus-1 presented by human histocompatibility leukocyte antigens-A2. Further, using 2C TCR- Ig, a more detailed analysis of the interaction with cognate peptide-MHC complexes revealed several interesting findings. Soluble divalent 2C TCR-Ig detected significant changes in the level of specific antigenic-peptide MHC cell surface expression in cells treated with gamma-interferon (gamma-IFN). Interestingly, the effects of gamma-IFN on expression of specific peptide-MHC complexes recognized by 2C TCR-Ig were distinct from its effects on total H-2 Ld expression; thus, lower doses of gamma-IFN were required to increase expression of cell surface class I MHC complexes than were required for upregulation of expression of specific peptide-MHC complexes. Analysis of the binding of 2C TCR-Ig for specific peptide-MHC ligands unexpectedly revealed that the affinity of the 2C TCR-Ig for the naturally occurring alloreactive, putatively, negatively selecting, complex, dEV-8-H-2 Kbm3, is very low, weaker than 71 microM. The affinity of the 2C TCR for the other naturally occurring, negatively selecting, alloreactive complex, p2Ca-H-2 Ld, is approximately 1000-fold higher. Thus, negatively selecting peptide-MHC complexes do not necessarily have intrinsically high affinity for cognate TCR. These results, uniquely revealed by this analysis, indicate the importance of using high affinity biologically relevant cognates, such as soluble divalent TCR, in furthering our understanding of immune responses.


Asunto(s)
Antígenos H-2/biosíntesis , Péptidos/inmunología , Péptidos/metabolismo , Receptores de Antígenos de Linfocitos T/biosíntesis , Animales , Unión Competitiva/inmunología , Biopolímeros/biosíntesis , Biopolímeros/inmunología , Biopolímeros/metabolismo , Cationes Bivalentes , Antígenos H-2/efectos de los fármacos , Antígenos H-2/metabolismo , Interferón gamma/farmacología , Ratones , Ratones Endogámicos BALB C , Ratones Transgénicos , Modelos Inmunológicos , Péptidos/efectos de los fármacos , Unión Proteica/genética , Unión Proteica/inmunología , Receptores de Antígenos de Linfocitos T/metabolismo , Proteínas Recombinantes de Fusión/metabolismo , Solubilidad , Células Tumorales Cultivadas
6.
Arch Biochem Biophys ; 330(2): 342-54, 1996 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-8660664

RESUMEN

In the absence of an electrochemical proton gradient, the F1 moiety of the mitochondrial ATP synthase catalyzes the hydrolysis of ATP. This reaction is inhibited by a natural protein inhibitor, in a process characterized by an increase in ATPase inhibition as pH is decreased from 8.0 to 6.0. In order to gain greater insight into the molecular and chemical events underlying this regulatory process, the relationships among pH, helicity of the inhibitor protein, and its capacity to inhibit F1-ATPase activity were examined. First, peptides corresponding to four regions of the 82-amino-acid inhibitor protein were chemically synthesized and assessed for both retention of secondary structure, and capacity to inhibit F1-ATPase activity. These studies showed that a region of only 24-amino-acid residues, from Phe 22 through Len 45, accounts for the inhibitory capacity of the inhibitor protein, and that retention of native helical structure in this region is not essential for inhibition. Second, three mutants (33P34, 39P40, and 43P44) of the intact inhibitor protein were prepared in which a proline residue was inserted within the inhibitory region to disrupt native helical structure. The secondary structures and inhibitory capacities of these mutants were analyzed as a function of pH. These studies revealed that, despite the initial loss of helical structure within the inhibitory region due to proline insertion, a further loss of helical structure is required to modulate inhibitory activity. These results suggest that a loss of helical structure outside the inhibitory region correlates with an increase in inhibitory capacity. Finally, two separate mutants (H48A and H55A) were prepared in which a conserved histidine residue in the wild-type inhibitor protein was replaced with an alanine. The secondary structures and inhibitory capacities of these mutants were also investigated as a function of pH. Results indicated that, although histidine residues do not directly affect the inhibitory capacity of the protein, they are important for maintaining the inhibitor protein in an inactive form at high pH. Furthermore, these results show that loss in helical structure, although correlated with an increase in inhibitory capacity, is not essential for this function. These novel experiments are consistent with a model in which the inhibitor protein is envisioned as consisting of two regions, an inhibitory region and a regulatory region. It is suggested that reduction of pH allows for the protonation of a histidine residue blocking the interaction between the two regions, thus activating the inhibitory response. The pH reduction also correlates with a partial unfolding of the protein that may either cause or result from the loss of interaction between the two helices. This unfolding may be necessary for further optimization of inhibitor function.


Asunto(s)
Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/farmacología , Proteínas/química , Proteínas/farmacología , ATPasas de Translocación de Protón/antagonistas & inhibidores , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Sitios de Unión , Histidina/química , Histidina/genética , Concentración de Iones de Hidrógeno , Técnicas In Vitro , Hígado/química , Mitocondrias/enzimología , Datos de Secuencia Molecular , Estructura Molecular , Mutagénesis Insercional , Mutagénesis Sitio-Dirigida , Oligodesoxirribonucleótidos/genética , Prolina/química , Prolina/genética , Estructura Secundaria de Proteína , Proteínas/genética , Ratas
8.
J Biol Chem ; 270(4): 1775-84, 1995 Jan 27.
Artículo en Inglés | MEDLINE | ID: mdl-7829514

RESUMEN

The F1 moiety of rat liver ATP synthase has a molecular mass of 370,000, exhibits the unique substructure alpha 3 beta 3 gamma delta epsilon, and fully restores ATP synthesis to F1-depleted membranes. Here we provide new information about rat liver F1 as it relates to the relationship of its unique substructure to its nucleotide binding properties, enzymatic states, and crystalline form. Seven types of experiments were performed in a comprehensive study. First, the capacity of F1 to bind [3H]ADP, the substrate for ATP synthesis and [32P]AMP-PNP (5'-adenylyl-beta,gamma-imidodiphosphate), a nonhydrolyzable ATP analog, was quantified. Second, double-label experiments were performed to establish whether ADP and AMP-PNP bind to the same or different sites. Third, total nucleotide binding was assessed by the luciferin-luciferase assay. Fourth, F1 was subfractionated into an alpha gamma and a beta delta epsilon fraction, both of which were subjected to nucleotide binding assays. Fifth, the nucleotide binding capacity of F1 was quantified after undergoing ATP hydrolysis. Sixth, the intensity of the fluorescence probe pyrene maleimide bound at alpha subunits was monitored before and after F1 experienced ATP hydrolysis. Finally, the catalytic activity and nucleotide content of F1 obtained from crystals being used in x-ray crystallographic studies was determined. The picture of rat liver F1 that emerges is one of an enzyme molecule that 1) loads nucleotide readily at five sites; 2) requires for catalysis both the alpha gamma and the beta delta epsilon fractions; 3) directs the reversible binding of ATP and ADP to different regions of the enzyme's substructure; 4) induces inhibition of ATP hydrolysis only after ADP fills at least five sites; and 5) exists in several distinct forms, one an active, symmetrical form, obtained in the presence of ATP and high P(i) and on which an x-ray map at 3.6 A has been reported (Bianchet, M., Ysern, X., Hullihen, J., Pedersen, P. L., and Amzel, L. M. (1991) J. Biol. Chem. 266, 21197-21201). These results are discussed within the context of a multistate model for rat liver F1 and also discussed relative to those reported for bovine heart F1, which has been crystallized with inhibitors in an asymmetrical form and has a propensity for binding nucleotides more tightly.


Asunto(s)
Adenosina Difosfato/metabolismo , Adenilil Imidodifosfato/metabolismo , Hígado/enzimología , Conformación Proteica , ATPasas de Translocación de Protón/química , ATPasas de Translocación de Protón/metabolismo , Adenosina Trifosfato/metabolismo , Animales , Sitios de Unión , Cromatografía Líquida de Alta Presión , Dicroismo Circular , Cristalización , Electroforesis en Gel de Poliacrilamida , Cinética , Sustancias Macromoleculares , Masculino , Modelos Estructurales , ATPasas de Translocación de Protón/aislamiento & purificación , Ratas , Ratas Sprague-Dawley , Espectrofotometría
9.
Biochemistry ; 33(26): 8017-28, 1994 Jul 05.
Artículo en Inglés | MEDLINE | ID: mdl-8025106

RESUMEN

To understand the structural basis of the 1500-fold decrease in catalytic activity of the D21E mutant of staphylococcal nuclease in which an aspartate ligand of the essential Ca2+ has been enlarged to glutamate, the conformation of the enzyme-bound substrate dTdA has been determined by NMR methods and has been docked into the X-ray structure of the D21E mutant (Libson, A. M., Gittis, A.G., & Lattman, E. E. Biochemistry, preceding paper in this issue) based on distances from the bound metal ion to dTdA and on intermolecular nuclear Overhauser effects from assigned aromatic proton resonances of Tyr-85, Tyr-113, and Tyr-115 to proton resonances of dTdA, using energy minimization to relieve small overlaps. Like the wild-type enzyme, the D21E mutant forms binary E-M and E-S and ternary E-M-S complexes with Ca2+, Mn2+, Co2+, and La3+. D21E enhances the paramagnetic effects of Co2+ on 1/T1 and 1/T2 of the phosphorus and on 1/T1 of four proton resonances of dTdA, and these effects are abolished by the binding of the competitive inhibitor 3',5'-pdTp. From the paramagnetic effects of enzyme-bound Co2+ on 1/T1 of phosphorus and protons, with the use of a correlation time of 1.1 ps based on 1/T1 values at 250 and 600 MHz, five metal-nucleus distances and 11 lower limit metal-nucleus distances have been calculated. The Co2+ to 31P distance of 4.1 +/- 0.9 A agrees with that found on the wild-type enzyme (Weber, D. J., Mullen, G. P., & Mildvan, A. S. (1991) Biochemistry 30, 7425-7437) and indicates at least 18% inner sphere phosphate coordination. Fourteen interproton distances and 109 lower limit interproton distances in dTdA in the ternary D21E-La(3+)-dTdA complex were determined by NOESY spectra at 50-, 100-, and 200-ms mixing times. Both the metal-nucleus and interproton distances were necessary to compute a narrow range of conformations for enzyme-bound dTdA. As on the wild-type enzyme, the conformation of dTdA on the D21E mutant is highly extended, with high-anti C-2' endo conformations for the individual nucleosides. However, significant conformational differences are found in the torsional angles chi of dA (delta chi = 49 +/- 3 degrees), in gamma of dT (delta gamma = 108 +/- 30 degrees) and in zeta of dT (delta zeta = 124 +/- 38 degrees).(ABSTRACT TRUNCATED AT 400 WORDS)


Asunto(s)
Nucleasa Microcócica/química , Mutación , Nucleótidos de Timina/química , Cobalto/química , Cobalto/metabolismo , Simulación por Computador , Cristalografía por Rayos X , Espectroscopía de Resonancia por Spin del Electrón , Espectroscopía de Resonancia Magnética , Manganeso/metabolismo , Metales/química , Metales/metabolismo , Nucleasa Microcócica/genética , Nucleasa Microcócica/metabolismo , Modelos Moleculares , Fósforo/química , Conformación Proteica , Protones , Staphylococcus/enzimología , Termodinámica , Nucleótidos de Timina/metabolismo , Volumetría
10.
N Y State Dent J ; 59(5): 43-8, 1993 May.
Artículo en Inglés | MEDLINE | ID: mdl-8510868

RESUMEN

Sinus grafting is a proven procedure with predictable results. However, practitioners need to be aware of and adhere to the details that dictate the success of the procedure.


Asunto(s)
Trasplante Óseo , Seno Maxilar/cirugía , Trasplante Óseo/métodos , Humanos , Hidroxiapatitas , Prótesis e Implantes
11.
Arch Biochem Biophys ; 301(1): 64-70, 1993 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-8442667

RESUMEN

The ATPase inhibitor protein of the rat liver mitochondrial ATP synthase/ATPase complex has been cloned from a rat liver cDNA library, and its nucleotide sequence determined. The sequence is highly homologous to both the bovine heart (approximately 70%) and the yeast inhibitor proteins (approximately 40%). The deduced protein sequence is 107 amino acids in length, and based on homology to the bovine heart protein, the first 25 N-terminal amino acids encode a putative mitochondrial targeting sequence. The "mature" protein (without the targeting sequence) fused to the maltose binding protein has been overexpressed in Escherichia coli. The maltose binding protein was used as a handle for the development of a rapid one-step purification of the fusion protein by affinity chromatography on an amylose resin. The purified fusion protein was cleaved with Factor Xa protease at the fusion junction, and the resulting ATPase inhibitor protein was purified to > 90% purity. The purified, overexpressed inhibitor protein displays normal inhibitor activity. The protein inhibits ATP hydrolysis catalyzed by the ATP synthase/ATPase complex in submitochondrial particles in a manner kinetically indistinguishable from the same protein purified from rat liver mitochondria, and exhibits a specific activity of approximately 10,000 units/mg. The secondary structure of the inhibitor protein was determined by circular dichroism spectropolarimetry. The experimentally determined structure shows a high content of alpha-helix and is in good agreement with sequence-based structural predictions. As the function of the inhibitor protein is known to exhibit a high dependence on pH, a study of the pH dependence of inhibitor secondary structure was performed. It is shown that as pH is lowered, conditions which activate inhibitory capacity, the protein loses significant alpha-helical structure. This is the first report of the overexpression in E. coli of a functional ATPase inhibitor protein. Secondary structural analysis of this protein indicates that conversion from its active to its inactive form involves a significant conformational change.


Asunto(s)
Adenosina Trifosfatasas/antagonistas & inhibidores , Clonación Molecular , Expresión Génica , Mitocondrias Hepáticas/enzimología , Proteínas/genética , ATPasas de Translocación de Protón/antagonistas & inhibidores , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Dicroismo Circular , Concentración de Iones de Hidrógeno , Datos de Secuencia Molecular , Estructura Secundaria de Proteína , Proteínas/química , Proteínas/farmacología , Ratas , Proteínas Recombinantes de Fusión/metabolismo , Proteínas Recombinantes de Fusión/farmacología , Análisis de Secuencia de ADN , Partículas Submitocóndricas/enzimología , Proteína Inhibidora ATPasa
12.
Arch Biochem Biophys ; 288(1): 243-9, 1991 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-1654825

RESUMEN

Phospholipase C from rat liver with a molecular weight of 87,000 (PLC delta) is stimulated by polyamines, basic proteins, and basic polyamino acids. The activation occurs in both the presence and the absence of detergents. Half-maximum activation by spermine is observed at 0.15 mM, with optimum effects between 0.2 and 0.5 mM. Spermine inhibits above 0.5 mM. Half-maximum activation by spermidine and putrescine is observed at 0.9 and 6 mM, respectively, with optimum effects at 2 and 5 mM, respectively. These polyamines also inhibit at higher concentrations. Neomycin activates the enzyme with an optimum concentration of 10 microM, but maximum activation is less than with polyamines. Half-maximum activation by histone 2B occurs at 0.5 micrograms/ml (36 nM), with maximum stimulation at 1.5 micrograms/ml. Other histones, protamine, melittin, poly-L-ornithine, poly-L-lysine, poly-D-lysine, and poly-L-arginine, activate optimally at 3-10 micrograms/ml. Myelin basic protein and lysozyme activate optimally at 50-100 micrograms/ml. Typical activations are three- to eightfold, but under some conditions the enzyme shows little or no activity in the absence of basic activators. The basic activators lower the salt concentration required for maximal activity. In the case of the detergent-micelle assay, histone shifts the optimum NaCl concentration from 350 to 200 mM for PIP2, from 260 to 100 mM for PIP, and from 150 to 0 mM for PI. Histone potentiates the activation by Ca2+, but does not shift the optimum Ca2+ concentration. The optimum salt and Ca2+ concentrations are linked, such that a decrease in the concentration of one decreases the optimum concentration of the other. Activation by histone is diminished by MgCl2 in a concentration-dependent manner.


Asunto(s)
Hígado/enzimología , Fosfolipasas de Tipo C/metabolismo , Animales , Activación Enzimática/efectos de los fármacos , Técnicas In Vitro , Cinética , Fosfatidilinositoles/metabolismo , Poliaminas/farmacología , Proteínas/farmacología , Ratas , Sales (Química)/farmacología
13.
J Oral Implantol ; 17(1): 16-21, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-1942128

RESUMEN

The shape, quantity, and quality of bone in the mandible and maxilla are significant factors in deciding which implant options are possible. An understanding of the importance of each of these factors is necessary for the successful diagnosis of edentulous and partially edentulous arches and for optimum use of the many devices and concepts being promoted to the profession and the public. This paper will discuss the differences between the bone of the mandible and the maxilla and between the dentulous and edentulous areas and how these affect implant treatment. Reestablishment of bone in deficient areas is also discussed.


Asunto(s)
Proceso Alveolar/anatomía & histología , Implantación Dental Endoósea , Arcada Edéntula/patología , Maxilares/anatomía & histología , Pérdida de Hueso Alveolar , Trasplante Óseo , Humanos
14.
J Oral Maxillofac Surg ; 43(1): 20-3, 1985 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-3855313

RESUMEN

Changing the dissection technique for gaining access to the temporomandibular joint decreased the incidence of facial nerve injury from 25% to 1.7%. This decrease can be attributed to the elimination of both development of a skin flap and dissection of tissue overlying the lateral capsule. Normal anatomic variation in the distribution of facial nerve branches may relate to the incidence of clinically apparent injury.


Asunto(s)
Disección/métodos , Traumatismos del Nervio Facial , Articulación Temporomandibular/cirugía , Procedimientos Quirúrgicos Dermatologicos , Músculos Faciales/inervación , Nervio Facial/anatomía & histología , Fasciotomía , Humanos , Parálisis/etiología , Colgajos Quirúrgicos , Músculo Temporal/cirugía
15.
J Dent Educ ; 46(9): 558-60, 1982 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-6955352

RESUMEN

A three-day workshop was designed for practicing oral and maxillofacial surgeons to review the clinical skills needed for preoperative assessment. The intent of the workshop was to prepare participants for broader hospital privileges under the new recommendations of the Joint Commission on Accreditation of Hospitals. The course was characterized by small group interaction and team-teaching involving physicians and oral and maxillofacial surgeons. Instruction included observation of simulated cases, a review of the documentation of such encounters, lecture-discussions, and examination of patients with positive physical findings.


Asunto(s)
Cuidados Preoperatorios , Cirugía Bucal/educación , Competencia Clínica , Diagnóstico , Humanos , Pronóstico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA